ILMN · XBRL financial data

Illumina financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ILMN's year ends in late December)

In millions of dollars	FY 2020Jan 3, 2021	FY 2021Jan 2, 2022	FY 2022Jan 1, 2023	FY 2023Dec 31, 2023	FY 2024Dec 29, 2024	FY 2025Dec 28, 2025
Revenue from contracts with customers	3,239	4,526	4,584	4,504	4,372	4,343
Cost of revenue	1,036	1,372	1,612	1,760	1,511	1,473
Gross profit	2,203	3,154	2,972	2,744	2,861	2,870
Research and development	682	1,185	1,321	1,354	1,169	967
Selling, general and administrative	941	2,092	1,297	1,612	1,092	1,086
Total operating expenses	1,623	3,277	7,151	3,813	3,694	2,063
Operating income (loss)	580	(123)	(4,179)	(1,069)	(833)	807
Interest income	41	0	11	58	46	40
Interest expense	49	61	26	77	100	101
Other income (expense)	284	1,068	(142)	(29)	(292)	340
Income tax expense (benefit)	200	122	68	44	44	236
Net income (loss)	656	762	(4,404)	(1,161)	(1,223)	850
Earnings per share, basic USD per share	4.48	5.07	(28.00)	(7.34)	(7.69)	5.47
Earnings per share, diluted USD per share	4.45	5.04	(28.00)	(7.34)	(7.69)	5.45
Weighted average shares, basic millions of shares	147	150	157	158	159	155
Weighted average shares, diluted millions of shares	148	151	157	158	159	156

Fiscal years (ILMN's year ends in late December)

In millions of dollars	FY 2020Jan 3, 2021	FY 2021Jan 2, 2022	FY 2022Jan 1, 2023	FY 2023Dec 31, 2023	FY 2024Dec 29, 2024	FY 2025Dec 28, 2025
Cash and cash equivalents	1,810	1,232	2,011	1,048	1,127	1,418
Short-term investments	1,662	107	26	6	93	215
Accounts receivable	487	648	671	734	735	854
Inventory	372	431	568	587	547	564
Prepaid and other current assets	152	295	285	234	244	238
Total current assets	4,483	2,713	3,561	2,609	2,746	3,289
Property and equipment, net	922	1,024	1,091	1,007	815	759
Right-of-use asset	532	672	653	544	419	370
Goodwill	897	7,113	3,239	2,545	1,113	1,113
Total assets	7,585	15,217	12,252	10,111	6,303	6,644
Accounts payable	192	332	293	245	221	240
Accrued liabilities	541	761	1,232	1,325	827	846
Current portion of long-term debt	511	0	—	—	—	—
Total current liabilities	1,244	1,093	2,773	1,570	1,547	1,585
Long-term debt	673	—	—	—	—	—
Lease liability, non-current	671	774	744	687	554	486
Retained earnings (accumulated deficit)	4,723	5,485	1,142	(19)	(1,242)	(392)
Total stockholders' equity	4,694	10,740	6,599	5,745	2,373	2,723
Total liabilities and equity	7,585	15,217	12,252	10,111	6,303	6,644
Common shares outstanding (cover page) millions of shares	146	≈157	158	159	158	153

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Fiscal years (ILMN's year ends in late December)

In millions of dollars	FY 2020Jan 3, 2021	FY 2021Jan 2, 2022	FY 2022Jan 1, 2023	FY 2023Dec 31, 2023	FY 2024Dec 29, 2024	FY 2025Dec 28, 2025
Net income (loss)	656	762	(4,404)	(1,161)	(1,223)	850
Stock-based compensation	194	754	366	380	370	275
Depreciation and amortization	187	251	394	432	354	270
Net cash from operating activities	1,080	545	392	478	837	1,079
Purchases of property and equipment	189	208	286	195	128	148
Net cash from investing activities	(554)	(1,069)	(591)	(231)	(178)	(55)
Proceeds from issuing common stock	61	60	63	67	56	44
Share repurchases	736	0	0	0	116	742
Proceeds from long-term debt	0	988	991	0	1,241	495
Net cash from financing activities	(766)	(51)	1,000	(1,210)	(570)	(744)
Net change in cash	(232)	(578)	779	(963)	79	291

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Illumina	1,289	1,129	419*	151.2M	Q3 FY26 10-QSep 27, 2026
Avantor	464	1,698	195*	677.6M	Q3 FY26 10-QSep 30, 2026
Revvity	1,023	730	192*	111.6M	Q2 FY26 10-QJul 5, 2026
Badger Meter	68	236	43*	28.6M	Q3 FY26 10-QSep 30, 2026
MKS	454	1,248	243*	67.6M	Q2 FY26 10-QJun 30, 2026
Teradyne	461	1,306	314*	156.1M	Q3 FY26 10-QSep 27, 2026
Itron	840	599	102*	43.9M	Q3 FY26 10-QSep 30, 2026
Vontier	266	757	116*	135.2M	Q2 FY26 10-QJul 3, 2026
Bio-Rad Laboratories	517	651	99*	not reported	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.